The Strategy for Predicting Future Exacerbation of Asthma Using a Combination of the Asthma Control Test and Lung Function Test

Journal of Asthma

Volumn 46, Issue 7, 2009, Pages 677-682

  Sato, Ryuji ^a   Tomita, Katsuyuki ^a   Sano, Hiroyuki ^a   Ichihashi, Hideo ^a   Yamagata, Shigeyoshi ^a   Sano, Akiko ^a   Yamagata, Toshiyuki ^a   Miyara, Takayuki ^a   Iwanaga, Takashi ^a   Muraki, Masato ^a   Tohda, Yuji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Exacerbation; Exhaled nitric oxide; Spirometry

Indexed keywords

NITRIC OXIDE; STEROID;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; LOW DRUG DOSE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

AGED; ALGORITHMS; ASTHMA; BREATH TESTS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 70249110034     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902972160     Document Type: Article

References (28)

1. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120(suppl):S94-S138.
2. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59-65.
3. Tomita K, Hanaki K, Hasegawa Y, Watanabe M, Sano H, Igishi T, Burioka N, Hitsuda Y, Horimukai K, Fukutani K, Sugimoto Y, Yamamoto M, Kato K, Ikeda T, Konishi T, Tokuyasu H, Kawasaki Y, Yajima H, Sejima H, Isobe T, Takabatake T, Shimizu E; San-in Asthma Research Group. Underrecog-nition of the severity of asthma and undertreatment of asthma in a rural area of Japan. J Asthma 2005; 42:689-696.
4. Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI): Bethesda (MD); 2006: 339.
5. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178.
6. McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR; American Lung Association Asthma Clinical Research Centers. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006; 118:1226-1233.
7. Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55:566-573.
8. Kitch BT, Paltiel AD, Kuntz KM, Dockery DW, Schouten JP, Weiss ST, Fuhlbrigge AL. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest 2004; 126:1875-1882.
9. Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: A key predictor of future exacerbations. Respir Med 2007; 101:481-489.
10. Cowie RL, Underwood MF, Revitt SG, Field SK. Predicting emergency department utilization in adults with asthma: A cohort study. J Asthma 2001; 38:179-184.
11. Adams RJ, Smith BJ, Ruffin RE. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55:566-573.
12. Eisner MD, Katz PP, Yelin EH, Shiboski SC, Blanc PD. Risk factors for hospitalization among adults with asthma: The influence of sociodemographic factors and asthma severity. Respir Res 2001; 2:53-60.
13. Federico MJ, Wamboldt FS, Carter R, Mansell A, Wamboldt MZ. History of serious asthma exacerbations should be included in guidelines of asthma severity. J Allergy Clin Immunol 2007; 119:50-56.
14. Green RH, Brighting CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts in randomized controlled trial. Lancet 2002; 360:1715-1721.
15. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41:471-476.
16. Gelb AF, Taylor CF, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129:1492-1499.
17. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405-1411.
18. American Thoracic Society/European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930.
19. Brieman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Belmont, CA: Wadsworth; 1984.
20. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE; GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170:836-844.
21. Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: The Profile of Asthma Risk Study: A prospective health maintenance organization-based study. Chest 2007; 132:1151-1161.
22. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Repir Crit Care Med 2001; 164:1376-1381.
23. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and metha-choline responsiveness in patients with mild asthma. Thorax 1998; 53:91-95.
24. Jones SL, kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor DR. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Repir Crit Care Med 2001; 164:738-743.
25. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41:471-476.
26. Shaw DE, Berry MA., Thomas M, Green RH, Brightling CE,Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: A randomized controlled trial. Am J Repir Crit Care Med 2007; 176:231-237.
27. Pijnenburg MW, Baller EM, Lever S, Hop WC, De Jongste JC. High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children. Clin Exp Allergy 2005; 35:920-925.
28. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364-369.